INS and infection: A 2022 meta-analysis demonstrated that intensive insulin therapy in abdominal and cardiac surgeries significantly reduced the incidence of surgical site infections, while another study suggested that maintaining perioperative blood glucose levels below 150 mg/dl decreases infection risk.27